Biodesix, Inc.
Clinical trials sponsored by Biodesix, Inc., explained in plain language.
-
Blood test aims to reduce unnecessary lung biopsies
Diagnosis OngoingThis study is testing whether a blood test called Nodify XL2 helps doctors better manage small, solid lung nodules found on CT scans. It involves 2,000 adults over 40 whose nodules are considered low to moderate risk for cancer. The goal is to see if the test results lead to fewe…
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
Massive study tracks how blood test influences lung cancer care
Knowledge-focused OngoingThis study is observing how doctors use a blood test called VeriStrat to help decide on treatments for patients with a common type of lung cancer. It involves over 5,000 patients and aims to see if the test results help predict which treatments work better for different people. T…
Sponsor: Biodesix, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC